CHEMICON International, Inc. (SERO) Expands Stem Cell Franchise Through Acquisition Of Specialty Media 
10/19/2005 5:12:48 PM

ATLANTA--(BUSINESS WIRE)--Feb. 22, 2005--Serologicals Corporation (NASDAQ: SERO) announced today that Chemicon International, Inc., its wholly-owned subsidiary, has acquired the assets of Specialty Media, a division of Cell & Molecular Technologies, owned by Sentigen Holding Corporation (NASDAQ: SGHL). Specialty Media, based in Phillipsburg, New Jersey, develops and supplies a variety of specialty stem cell culture media formulations and supplements, cells and research reagent tools to the life sciences industry. Serologicals acquired all of the assets of Specialty Media for $6.5 million in cash.